United States

ERBA Diagnostics Inc (ERB.A)

ERB.A on American Stock Exchange

28 Sep 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ERB.A


ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures and markets diagnostic test kits, or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology and diabetes testing. The Company's... (more)
No analyst recommendations are available for ERB.A.


Beta: 0.30
Market Cap(Mil.): $24.38
Shares Outstanding(Mil.): 44.09
Dividend: --
Yield (%): --


  ERB.A Industry Sector
P/E (TTM): -- 37.43 36.51
EPS (TTM): -0.04 -- --
ROI: -9.11 12.48 13.85
ROE: -9.95 14.80 14.77

BRIEF-Erba Diagnostics announces NYSE notice of noncompliance

* Erba Diagnostics, Inc. announces notice of noncompliance with nyse market continued listing standards Source text for Eikon: Further company coverage:

Aug 26 2016

BRIEF-Erba Diagnostics files for non-timely 10-Q - Sec Filing

* Intends to include restated financial statements for restatement periods and financial statements as of and for year ended December 31, 2015 Source text for Eikon: Further company coverage:

Aug 16 2016

BRIEF-ERBA Diagnostics files for non-timely 10-K

* Anticipates filing annual report on form 10-K and quarterly report on form 10-Q for quarter ended September 30, 2015 by May 25 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Mar 31 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Pechala's Reports
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : MacroRisk Analytics/EconomicInvestor
Provider : Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.